Does RELUGOLIX Cause Stent placement? 49 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Stent placement have been filed in association with RELUGOLIX (Orgovyx). This represents 0.2% of all adverse event reports for RELUGOLIX.
49
Reports of Stent placement with RELUGOLIX
0.2%
of all RELUGOLIX reports
0
Deaths
24
Hospitalizations
How Dangerous Is Stent placement From RELUGOLIX?
Of the 49 reports, 24 (49.0%) required hospitalization.
Is Stent placement Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RELUGOLIX. However, 49 reports have been filed with the FAERS database.
What Other Side Effects Does RELUGOLIX Cause?
Hot flush (6,845)
Fatigue (5,203)
Therapy interrupted (3,251)
Incorrect dose administered (1,917)
Asthenia (1,718)
Arthralgia (1,385)
Diarrhoea (1,383)
Product dose omission issue (1,189)
Dizziness (1,146)
Constipation (902)
What Other Drugs Cause Stent placement?
RANOLAZINE (593)
EVOLOCUMAB (244)
ADALIMUMAB (227)
ROSIGLITAZONE (196)
ETANERCEPT (174)
CLOPIDOGREL BISULFATE (167)
RIVAROXABAN (122)
ASPIRIN (118)
APIXABAN (116)
MACITENTAN (108)
Which RELUGOLIX Alternatives Have Lower Stent placement Risk?
RELUGOLIX vs REMDESIVIR
RELUGOLIX vs REMERON
RELUGOLIX vs REMICADE
RELUGOLIX vs REMIFENTANIL
RELUGOLIX vs REMIMAZOLAM